Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine.

ABSTRACT:

Background

The SARS-CoV-2 pandemic has led to the development of the first mRNA vaccines used in humans. The vaccines are well tolerated, safe, and highly efficacious; however, post-marketing surveillance is revealing potential rare adverse effects. We report a case of symptomatic acute myocarditis following administration of the second dose of mRNA-1273 SARS-CoV-2 vaccine.

Case summary

A 44-year-old man presented with chest pain and ST-segment elevation 4 days after receiving the second dose of mRNA-1273 SARS-CoV-2 Vaccine. Emergent coronary angiogram showed minimal coronary artery disease. Cardiac magnetic resonance imaging confirmed acute myocarditis. Diagnosis of vaccine-associated myocarditis was made given the temporal relationship and supportive treatment initiated. F

SUBMITTER: Tailor PD 

PROVIDER: S-EPMC8422333 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature